# OnCo record kc1036 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/kc1036/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "kc1036" ;
  schema:name "KC1036"@en ;
  schema:description "KC1036 is an experimental small-molecule drug from Beijing Konruns Pharmaceutical in phase 3 trials for oesophageal cancer, ewing sarcoma and thymoma and thymic carcinoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/kc1036/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=KC1036> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule (structure undisclosed or not yet in PubChem)" ;
  onco:cancers <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/ewing-sarcoma/>, <https://onco.cc/cancers/thymic-epithelial/> ;
  onco:companies <https://onco.cc/companies/shanghai-kechow-pharma/> ;
  onco:trials <https://onco.cc/trials/nct06194734/> .